Earth Science Tech, Inc. (OTC: ETST) Delivers Transformational FY2026 Results and Expands Debt-Free Growth Strategy
Miami, FL – June 10, 2026 – Earth Science Tech, Inc. (OTC: ETST), a diversified strategic holding company focused on the health and wellness sector, has released its annual shareholder letter for the fiscal year ended March 31, 2026. The company’s CEO and Chairman, Giorgio R. Saumat, outlined a year of significant milestones, financial achievements, and a clear roadmap for disciplined, debt-free growth. The developments outlined are highly relevant for shareholders and could have a material impact on ETST’s share valuation.
Key Highlights from FY2026
- Over 6.9 Million Shares Repurchased: Since the start of fiscal Q1 2026, ETST has repurchased more than 6.9 million shares of its common stock, with 3,773,296 shares retired during the fiscal year and an additional 3,150,392 shares retired quarter-to-date. This aggressive buyback demonstrates management’s confidence in the company’s future and reduces share dilution, potentially boosting shareholder value.
- Revenue Milestones: The Peaks Curative platform achieved a significant milestone, surpassing \$2 million in revenue in the first week of fiscal Q4 2026. This is a testament to the company’s robust marketing efforts and operational execution.
- Consistent Cash Flow Positivity: All major operating segments, including new acquisitions and the redesigned MyOnlineConsultation (MOC Teledoc) prescriber network, have been cash flow positive from the outset of operations.
- Debt-Free Expansion: All recent growth initiatives, property developments, and acquisitions were executed without incurring any additional debt, preserving balance sheet strength and positioning the company for sustainable long-term expansion.
- Regulatory Progress: After a protracted process, FINRA cleared ETST’s Form 211 in December, supporting the company’s compliance and capital markets activities.
- New Developments and Asset Monetization: The first residential property at Avenvi has been built, permitted, and is under contract for sale. The company also holds three additional properties awaiting final permit approval, signaling near-term potential for further asset monetization.
Strategic and Operational Achievements
Expansion of Core Holdings: ETST successfully turned around recently acquired assets—DOConsultation and Villas Health—making them both cash flow positive. Meanwhile, the Texas property housing Mister Meds has been built from the ground up, and operations continue to strengthen.
Technology and Telemedicine: The company completed a comprehensive redesign of its proprietary technology stack, relaunching MyOnlineConsultation (MOC Teledoc) as a prescriber network. This segment has delivered consistent cash flow positivity since day one, reflecting ETST’s ability to innovate and capture new market opportunities in digital health.
Business Segmentation and Future Outlook
Effective March 31, 2026, ETST will report its financial results across two primary segments for increased transparency: Health/Wellness (the company’s core operating engine) and Corporate/Other. The Health/Wellness segment is expected to drive the bulk of 2027 revenue, leveraging rising volumes, growing provider relationships, and a vertically integrated business model. Corporate/Other continues to generate strong cash flow, with multiple properties positioned for near-term development or sale.
The company anticipates geographic expansion of all subsidiary businesses in the coming year and will pursue additional acquisitions or partnerships where strategically advantageous.
Shareholder-Focused Initiatives
- Share Buybacks: The company’s aggressive share repurchase program is a clear signal of management’s confidence in ETST’s intrinsic value and a direct effort to enhance shareholder returns.
- Debt-Free Strategy: Notably, all key accomplishments—including acquisitions, operational turnarounds, technology upgrades, and property development—were achieved without taking on additional debt. This prudent financial approach significantly reduces risk and preserves flexibility for future growth.
- Event Participation: Shareholders can expect direct engagement at the upcoming Planet Microcap Conference in Las Vegas from June 16-18 and at the annual shareholder meeting following the 10-K filing (date TBD).
About Earth Science Tech, Inc. (ETST)
ETST operates as a diversified holding company focused on building a vertically integrated healthcare platform encompassing compounding pharmacy operations, telemedicine, clinical support, direct-to-patient fulfillment, and supported by real estate and consumer products businesses. The company’s value proposition centers on seamless integration of patient care from consultation to fulfillment, leveraging synergies across specialized subsidiaries.
Potential Share Price Catalysts and Investor Considerations
- The substantial share buyback program and reduction in outstanding shares is likely to positively impact EPS and may provide support for the company’s share price.
- Debt-free growth, strong cash flows, and consistent profitability across new and legacy business units reduce financial risk and enhance the company’s attractiveness to long-term investors.
- Clear revenue growth at Peaks Curative and successful integration of new assets signal effective execution and a strong growth trajectory.
- Upcoming property sales and developments could provide further cash inflows and optionality for capital deployment or shareholder returns.
- Regulatory clearance of Form 211 by FINRA positions the company for improved capital markets access and potential uplisting or financing opportunities.
CEO Statement
“We measure our progress not only by the milestones we reached, but by the capabilities we built to reach the ones still ahead. I believe we set the stage for the next leg of our journey: the chapter in which Earth Science Tech turns from a bold endeavor into a lasting legacy… We began the new fiscal year in a position of real financial strength.” – Giorgio R. Saumat, CEO & Chairman
Contact Information
For further information, investors can contact Hayden IR:
James Carbonara: (646)-755-7412, [email protected]
Brett Maas: (646)-536-7331, [email protected]
Disclaimer: This article contains forward-looking statements as defined under U.S. securities laws. Actual results may differ materially due to various risks and uncertainties. This is not a recommendation to buy or sell securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions.
